Rapid Emergence of High-Level Resistance to Quinolones in Campylobacter jejuni Associated with Mutational Changes in gyrA and parC
- 1 December 1998
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 42 (12) , 3276-3278
- https://doi.org/10.1128/aac.42.12.3276
Abstract
Quinolone resistance in clinical isolates of Campylobacter jejuni in Sweden increased more than 20-fold at the beginning of the 1990s. Resistance to 125 μg of ciprofloxacin per ml in clinical isolates was associated with chromosomal mutations in C. jejuni leading to a Thr-86-Ile substitution in the gyrA product and a Arg-139-Gln substitution in the parC product.Keywords
This publication has 18 references indexed in Scilit:
- Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 1995
- Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutationsAntimicrobial Agents and Chemotherapy, 1993
- Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up reportAntimicrobial Agents and Chemotherapy, 1992
- Active efflux mechanisms for antimicrobial resistanceAntimicrobial Agents and Chemotherapy, 1992
- Rapid Emergence of Quinolone Resistance in Campylobacter jejuni in Patients Treated with NorfloxacinScandinavian Journal of Infectious Diseases, 1992
- Capture PCR: efficient amplification of DNA fragments adjacent to a known sequence in human and YAC DNA.Genome Research, 1991
- Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coliAntimicrobial Agents and Chemotherapy, 1991
- New topoisomerase essential for chromosome segregation in E. coliCell, 1990
- Endogenous active efflux of norfloxacin in susceptible Escherichia coliAntimicrobial Agents and Chemotherapy, 1988
- Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAOAntimicrobial Agents and Chemotherapy, 1988